Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

USDA to Fund Research to Combat Citrus Greening Disease

XTALKS VITALS NEWS

Oranges

The plant pathogen has spread throughout Florida’s citrus-growing areas, causing a 75 percent decline in the state’s $9 billion citrus industry.

Share this!

January 23, 2017 | by Sarah Hand, M.Sc.

The US Department of Agriculture’s (USDA) National Institute of Food and Agriculture (NIFA) has announced a $13.6 million investment in research on citrus greening disease – also known as Huanglongbing (HLB). The bacterial disease is a major threat to US citrus industry.

“The economic impact of citrus greening disease is measured in the billions,” said NIFA Director Sonny Ramaswamy. “NIFA investments in research are critical measures to help the citrus industry survive and thrive, and to encourage growers to replant with confidence.”

In 2005, the first citrus trees infected with HLB were identified in Florida. Since then, the plant pathogen has spread throughout Florida’s citrus-growing areas, causing a 75 percent decline in the state’s $9 billion citrus industry.



The Asian citrus psyllid (ACP) – an insect vector of HLB – has been found in 15 US states and territories, which have since been put under quarantine. Between 2009 and now, the USDA has invested over $400 million in citrus greening research.

In the current funding period, the USDA provided four grants to researchers at Clemson University, Regents of the University of California, Iowa State University and the USDA Agricultural Research Service (ARS). The four research centers are addressing the issue of HLB from a number of different angles.

For example, the Clemson University researchers are using the CRISPR/Cas9 genome editing technology to develop HLB-resistant citrus varieties. The Iowa State University scientists will investigate the role of soil bacteria in controlling HLB.

Past recipients of the USDA grants have developed bactericides to eliminate HLB from infected plants, and encourage future fruit production. Other previous studies have taken a preventive approach by developing citrus rootstocks with HLB immunity, using bacterial-derived virulence proteins.


Keywords: USDA, Food, Agriculture


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor

March 23, 2017 - Most US patients hoping to get their PCSK9 inhibitor medications covered by their prescription drug plan are being denied, according to two new studied conducted by Amgen.

Featured In: Biotech News


Smartphone App Created Using Apple’s ResearchKit Used to Conduct Asthma Clinical Studies

March 22, 2017 - Researchers at the Icahn School of Medicine at Mount Sinai have conducted a large-scale, observational study of asthma patients using the Apple ResearchKit framework and the Asthma Health app on patients’ iPhones.

Featured In: Clinical Trials News


IBS Patients Taking Viberzi May Be at Increased Risk of Pancreatitis

March 22, 2017 - According to a recent drug safety communication issued by the US Food and Drug Administration (FDA), patients with irritable bowel syndrome (IBS) with diarrhea should not be treated using Viberzi (eluxadoline), if they do not have a gallbladder.

Featured In: Drug Safety News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

How to Improve the Speed and Efficiency of Your Clinical Trials


High Performance Computing for High Content Screening - A Case Study


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Treatment of Psoriasis: Improvements Through Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.